Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of... (trials@hgsi.com clinical

Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of Directors

Date:5/8/2008

trials@hgsi.com">clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

SAFE HARBOR STATEMENT

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. government will not be required to reimburse the Company for the costs incurred or to purchase any ABthrax doses, and we will not receive any of the expected revenues relative to ABthrax. Existing and prospective inv
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. St. Jude finds dancing hair cells are key to humans acute hearing
2. Six Youths Secure Top Spots in American Humane Kind Kid Contest
3. AVMA Passes New Policy to Encourage Humane Treatment of Captive Elephants, Appropriate Use of Training Tools
4. Researchers Develop Quick Way to Create Human Antibodies
5. American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Womens Shelters
6. J. Craig Venter, Human Genome Pioneer, to Receive Award at Vietnam Veterans of Americas National Leadership Conference
7. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
8. Mutation in human gene helps protect against fatal malaria
9. Scientists Explore Human Gene Pool With Help From Microsoft Research
10. Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources
11. European Society of Human Reproduction & Embryology 24th annual meeting

Post Your Comments:

(Date:12/14/2009)... ARBOR, Mich., Dec. 14 Pepsi ... the Commonwealth of Kentucky are among the major ... this fall to help their employees make better ... solution gives employees a personalized summary of their ... of that care. With this personalized information, employees ...

(Date:12/14/2009)... Haemonetics Corporation (NYSE: HAE ... new legal action to stop Fenwal Inc.,s continued ... cell collection kits, using a modified separation chamber. ... circumvent Haemonetics, patent and the injunction entered by ... products after December 1, 2010. According to ...

(Date:12/14/2009)... -- Tough Enough To Wear Pink(TM) (TETWP), the ... its fifth anniversary at the signature Tough Enough ... Finals Rodeo (Wrangler NFR) in Las Vegas. While ... cowboys, the support of the western industry and ... sported pink shirts, hats, bracelets and more. ...

(Date:12/14/2009)... , ... La Jolla, Calif. (Vocus) -- The physicians ... as the new chief of staff of the 372-bed facility. Dr. ... on Jan. 1, 2010. , , , , ,During his two-year ... La Jolla’s administrative staff and its board of directors. Dr. Sedwitz ...

(Date:12/14/2009)... Tens of Thousands of New Chronic Hepatitis Infections ... Legislation approved by Congress providing for federal funding ... to reduce tens of thousands of new viral ... States, the National Viral Hepatitis Roundtable ... in the FY 2010 Consolidated Appropriations bill approved ...

Breaking Medicine News(10 mins):Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4 Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2 Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3 Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2

[0] Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process [0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement [0] Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary [1] New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla [0] NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange

... COLLEGEVILLE, Pa., May 15 Wyeth Pharmaceuticals, a,division ... that PRISTIQ(TM),(desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI),approved ... (MDD), is,now available in U.S. retail pharmacies nationwide. ... once daily. The Company begins full-scale,selling and educational ...

... HealthSTAR Public Relations, LLC,(HSPR) announced today that Hayley ... Prior to joining HSPR, Soffer managed the healthcare ... has 14,years of industry experience at agencies including Porter ... majority of her career. She began,her career at Makovsky ...

... Va. The International Association for Dental Research ... 2008 winners of the annual IADR/GSK Innovation in ... in innovative oral care technologies that may maintain ... , Sharing the $225,000 unrestricted research grant, which ...

... we had (and still have) a home-grown relative of this ... Missouri in the autumn of 1933, a disease that is ... people. Now, a new analysis of the genome of St. ... at the American Museum of Natural History (AMNH) is shedding ...

... Pressure Control Doubled with ICG-Guided Therapy On Over 76,000+ ... ... SAN DIEGO, May 15 CardioDynamics (Nasdaq:,CDICD), the innovator and ... cardiac monitoring systems, today,announced the presentation of a significant independent ...

... to Pain and Injury Risk, ALEXANDRIA, Va., May ... that biking to work not only provides,excellent health benefits ... Bike to Work Day on Friday, May 16, the ... lower their,risk of injury by ensuring that their bicycles ...

Other Medicine News:Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 2 Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 3 Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 4 Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 5 Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 6 Health News:Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 7 Health News:HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President 2 Health News:IADR and GlaxoSmithKline Consumer Healthcare announce winners 2 Health News:IADR and GlaxoSmithKline Consumer Healthcare announce winners 3 Health News:Geneticists at the American Museum of Natural History trace the evolution of St. Louis encephalitis 2 Health News:CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting 2 Health News:CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting 3 Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 2 Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 3 Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 4

Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President IADR and GlaxoSmithKline Consumer Healthcare announce winners Geneticists at the American Museum of Natural History trace the evolution of St. Louis encephalitis CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day

(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...

(Date:12/14/2009)... Cardinal Health today announced that executives of ... ,, Goldman Sachs CEO Unplugged Conference ... Sachs Conference Center in New York. 28th ... at Noon EST at the Westin St. Francis Hotel ... executives will discuss Cardinal Health,s diverse products and services, ...

(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...

Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9 Cardinal Health Executives to Speak at Two Investor Events in January 2 Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 1 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 3 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 4 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 1 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 2 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 3 Genova files patent for new prostate cancer treatment 56395 1 Genova files patent for new prostate cancer treatment 56395 2

[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium [0] Cardinal Health Executives to Speak at Two Investor Events in January [0] Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.

... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...

... I Clinical Data and Additional Preclinical Results for Non-Nucleoside ... Polymerase Inhibitor Being Presented at AASLD, SAN DIEGO, Nov. ... the results of a Phase I clinical trial,of ANA598 in ... of the leading non-nucleoside polymerase inhibitors,currently in development for the ...

Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

All welded construction for strength and durability. Choice of stainless steel or chrome plated models....

... Motorized tilt, user programmable memory two ... control on both chair sides, solid ... base. Single button folding armrests and ... handle on both chair sides, ergonomically ...

... A practical, comfortable chair for ... seat height is adjustable from ... by use of an independent ... rotatable through 360 and incorporates ...

Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....

Medicine Products:

P-1068-SS Examination Chair OC-2400 MAC-150E Patient Chair Heine Beta 200 Streak Retinoscope 3.5v w/ Twist Lock

Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of...(trials@hgsi.com clinical_trials@hgsi.com...),Health